De ce și-au schimbat medicii părerea despre timus, organul considerat inutil după pubertate: legătura cu longevitatea și riscul de cancer – HotNews.ro

Medical understanding of the thymus gland is shifting as researchers uncover its continued importance in adult health, challenging the long-held belief that the organ becomes obsolete after puberty.

Traditionally, the thymus—a small gland located in the upper chest behind the sternum—was viewed as a temporary organ. Its primary role is to train T-lymphocytes, or T-cells, which are critical components of the adaptive immune system responsible for identifying and destroying pathogens and cancerous cells.

For decades, clinical consensus maintained that the thymus undergoes a process called involution, where the functional lymphoid tissue is gradually replaced by adipose tissue starting at puberty. This led to the assumption that the organ provided little to no benefit to adults.

Recent reporting and scientific analysis, highlighted by outlets including HotNews.ro, indicate that the thymus remains active throughout a person’s lifespan, and its rate of decline is closely linked to biological aging, cancer risk, and overall longevity.

The thymus acts as a specialized school for the immune system. It takes immature T-cells produced in the bone marrow and puts them through a rigorous selection process to ensure they can recognize foreign invaders without attacking the body’s own healthy tissues.

When the thymus shrinks during involution, the production of new, naive T-cells drops significantly. Naive T-cells are essential because they have not yet encountered a specific antigen and are therefore capable of responding to new, previously unseen threats, such as emerging viral strains or mutating cancer cells.

As the pool of naive T-cells diminishes with age, the body relies more heavily on memory T-cells—cells that remember previous infections. While effective for recurring threats, this reliance leaves the elderly more vulnerable to new infections and less capable of mounting an effective immune response to vaccinations.

This biological decline is a cornerstone of immunosenescence, the gradual deterioration of the immune system associated with aging. Researchers are now investigating how maintaining thymic function may extend the period of healthy life, or healthspan.

The link between the thymus and cancer risk is rooted in the concept of immunosurveillance. The immune system constantly patrols the body for cells that have become malignant. T-cells are the primary executors of this surveillance.

A more robust and active thymus in adulthood ensures a steady supply of diverse T-cells. This diversity increases the likelihood that the immune system will detect and eliminate precancerous cells before they develop into clinical tumors.

Conversely, accelerated thymic involution is often observed in individuals with chronic stress, severe malnutrition, or certain autoimmune conditions, which may correlate with a higher susceptibility to age-related diseases.

Current research is exploring whether the process of involution can be slowed or partially reversed. Some studies have looked into the role of specific growth factors and hormones that might stimulate the regeneration of thymic epithelial cells, the structural cells that support T-cell maturation.

Other investigations focus on the impact of lifestyle factors on thymic health. While the genetic blueprint for involution is strong, evidence suggests that metabolic health and the reduction of chronic inflammation may help preserve the remaining functional capacity of the gland.

Despite these findings, medical professionals caution that thymic regeneration is not yet a standard clinical treatment. Most current interventions are experimental and are being tested in controlled research settings rather than general practice.

The transition in perspective regarding the thymus reflects a broader trend in geriatric medicine: moving away from viewing aging as an inevitable series of failures and toward treating the biological drivers of decline.

By identifying the thymus as a key regulator of lifelong immunity, scientists hope to develop strategies that not only prolong life but ensure the immune system remains capable of protecting the body well into old age.

The focus now remains on determining the precise triggers of involution and whether pharmacological or therapeutic interventions can safely restore T-cell production without increasing the risk of autoimmune disorders, which can occur if T-cells are not properly screened by the thymus.